Arda Kayhan

Arda Kayhan

Auto-generated profile, based on publicly available information

Arda Kayhan

Department of Radiology, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, 34303, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in World Journal of Radiology
Verified
Journal Article
Open access
AKArda Kayhan
Arda Kayhan
XFXiaobing Fan
Xiaobing Fan
JOJacob Oommen
Jacob Oommen
AOAytekin Oto
Aytekin Oto
Magnetic resonance (MR) imaging has been increasingly used in the evaluation of prostate cancer. As studies have suggested that the majority of cancers arise from the peripheral zone (PZ), MR imaging has focused on the PZ of the prostate gland thus far. However, a considerable number of cancers (up to 30%) originate in the transition zone (TZ), substantially contributing to morbidity and mortality. Therefore, research is needed on the TZ of the prostate gland. Recently, MR imaging and advanced MR techniques have been gaining acceptance in evaluation of the TZ. In this article, the MR imaging features of TZ prostate cancers, the role of MR imaging in TZ cancer detection and staging, and recent advanced MR techniques will be discussed in light of the literature.

1 January 2010 in World Journal of Radiology
Verified
Journal Article
Open access
AKArda Kayhan
Arda Kayhan
JOJacob Oommen
Jacob Oommen
FDFarid Dahi
Farid Dahi
AOAytekin Oto
Aytekin Oto
Magnetic resonance enterography in Crohn’s disease: Standard and advanced techniques

1 June 2014 in European Journal of Radiology
Verified
Journal Article
Closed access
FBFatma Nur Soylu Boy
Fatma Nur Soylu Boy
AKArda Kayhan
Arda Kayhan
HKHakki Muammer Karakas
Hakki Muammer Karakas
FUFeyza Unlu-Ozkan
Feyza Unlu-Ozkan
DSDuygu Silte
Duygu Silte
IAİlKnur Aktas
İlKnur Aktas

1 November 2010 in Clinical Imaging
Verified
Journal Article
Closed access
AKArda Kayhan
Arda Kayhan
HLHatice Lakadamyali
Hatice Lakadamyali
JOJacob Oommen
Jacob Oommen
AOAytekin Oto
Aytekin Oto

1 June 2010 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
AKArda Kayhan
Arda Kayhan
YIYashar Ilkhchoui
Yashar Ilkhchoui
NVNanda Venu
Nanda Venu
DJDonald M. Jensen
Donald M. Jensen
AOAytekin Oto
Aytekin Oto

1 March 2012 in European Journal of Radiology
Verified
Journal Article
Open access
PDF file
AKArda Kayhan
Arda Kayhan
FPFigen Palabıyık
Figen Palabıyık
SSSerdar Serinsöz
Serdar Serinsöz
AKAdem Kırış
Adem Kırış
SBSibel Bayramoğlu
Sibel Bayramoğlu
TCTan Cimilli
Tan Cimilli
To prospectively compare the efficacy of 40-row multidetector computed tomography angiography (MDCTA) and duplex ultrasonography (DUS) to diagnose mild peripheral arterial occlusive disease (PAOD) in lower leg and to search whether MDCTA can be used as a screening tool. Forty-three patients with intermittent claudication and leg pain, diagnosed as mild PAOD, had undergone DUS and MDCTA of lower limb. The arteries of lower leg were initially scanned by DUS, followed by MDCTA. Both modalities were compared for detecting the obstructed and stenotic segments. A total of 774 vessel segments were imaged by both modalities. When all arteries were considered, MDCTA detected obstructed or stenotic lesions in 16.8% of arteries, versus 11.1% compared to DUS. When suprapopliteal arteries alone were considered, MDCTA detected lesions in 15.0% of arteries, versus 11.0% with DUS. When infrapopliteal arteries only were considered, MDCTA detected lesions in 19.6% of arteries, versus 11.3% with DUS. MDCTA showed 5.7% (95% CI: [3.5%, 7.9%]) more lesions than DUS when all arteries were considered together, 8.3% (95% CI: [4.6%, 12.0%]) more lesions when only the infrapopliteal arteries were compared, and 4.0% (95% CI: [1.3%, 6.8%]) more lesions when only suprapopliteal arteries were compared (p<0.01 for all comparisons). 40-row MDCTA may be used as a screening tool in patients with mild lower extremity PAOD as it is a non-invasive and more accurate modality when compared to DUS.